Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
GCase activator 3 is an activator of β-glucocerebrosidase (GCase) with a half-maximal activation concentration (AC50) value of 1.49 µM.1 It increases GCase protein levels and activity and reduces mutant GCase protein misfolding in Gaucher disease patient-derived fibroblasts expressing the reduction-in-function GBA1N370S mutation and the loss-of-function GBA184GG mutation. GCase activator 3 (5 and 15 µM) also increases GCase protein levels and activity in midbrain dopaminergic neurons derived from Parkinson’s disease patient-derived induced pluripotent stem cells (iPSCs) and GBA1N370S-expressing iPSCs, both generated from skin fibroblasts.
WARNING This product is not for human or veterinary use.
1. Correction to conversion of quinazoline modulators from inhibitors to activators of β-